Literature DB >> 33759084

Antiparkinsonian activity of Cucurbita pepo seeds along with possible underlying mechanism.

Uzma Saleem1, Aisha Shehzad2, Shahid Shah3, Zohaib Raza2, Muhammad Ajmal Shah4, Shabana Bibi5,6, Zunera Chauhdary2, Bashir Ahmad7.   

Abstract

Cucurbita pepo is used as a vegetable in Pakistan and its seeds are also rich in tocopherol. Data showed the pivotal role of tocopherol in the treatment of Parkinson's disease (PD). The current study was designed to probe into the antiparkinson activity of methanolic extract of C. pepo (MECP) seeds in the haloperidol-induced Parkinson rat model. Behavioral studies showed improvement in motor functions. The increase in catalase, superoxide dismutase, glutathione levels whereas the decreases in the malondialdehyde and nitrite levels were noted in a dose-dependent manner. Acetylcholine-esterase (AchE) activity was increased. Molecular docking results revealed significant binding interaction of selected phytoconstituents within an active site of target protein AchE (PDB ID: 4EY7). Furthermore, α-synuclein was up regulated with down regulation of TNF-α and IL-1β in the qRT-PCR study. Subsequently, ADMET results on the basis of structure to activity predictions in terms of pharmacokinetics and toxicity estimations show that selected phytochemicals exhibited moderately acceptable properties. These properties add knowledge towards the structural features which could improve the bioavailability of selected phytochemicals before moving towards the initial phase of the drug development. Our integrated drug discovery scheme concluded that C. pepo seeds could ameliorate symptoms of PD and may prove a lead remedy for the treatment of PD.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  ADMET; Cucurbita pepo; Haloperidol; Molecular docking; PCR; Parkinson’s disease

Mesh:

Substances:

Year:  2021        PMID: 33759084     DOI: 10.1007/s11011-021-00707-6

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  27 in total

Review 1.  Genetics of Parkinson disease: paradigm shifts and future prospects.

Authors:  Matthew James Farrer
Journal:  Nat Rev Genet       Date:  2006-04       Impact factor: 53.242

Review 2.  Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment.

Authors:  K Ray Chaudhuri; Anthony H V Schapira
Journal:  Lancet Neurol       Date:  2009-05       Impact factor: 44.182

3.  Novel action of vinpocetine in the prevention of paraquat-induced parkinsonism in mice: involvement of oxidative stress and neuroinflammation.

Authors:  Ismail O Ishola; A A Akinyede; T P Adeluwa; C Micah
Journal:  Metab Brain Dis       Date:  2018-06-01       Impact factor: 3.584

4.  New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays.

Authors:  Jonathan B Baell; Georgina A Holloway
Journal:  J Med Chem       Date:  2010-04-08       Impact factor: 7.446

5.  Involvement of adenosinergic receptor system in an animal model of tardive dyskinesia and associated behavioural, biochemical and neurochemical changes.

Authors:  Mahendra Bishnoi; Kanwaljit Chopra; Shrinivas K Kulkarni
Journal:  Eur J Pharmacol       Date:  2006-09-19       Impact factor: 4.432

6.  Adaptation of a ladder beam walking task to assess locomotor recovery in mice following spinal cord injury.

Authors:  Brian J Cummings; Christie Engesser-Cesar; Gilbert Cadena; Aileen J Anderson
Journal:  Behav Brain Res       Date:  2007-01-02       Impact factor: 3.332

7.  Acetylcholinesterase: from 3D structure to function.

Authors:  Hay Dvir; Israel Silman; Michal Harel; Terrone L Rosenberry; Joel L Sussman
Journal:  Chem Biol Interact       Date:  2010-02-04       Impact factor: 5.192

8.  Isolation and solubilization of proteins after TRIzol extraction of RNA and DNA from patient material following prolonged storage.

Authors:  Amanda B Hummon; Sharlene R Lim; Michael J Difilippantonio; Thomas Ried
Journal:  Biotechniques       Date:  2007-04       Impact factor: 1.993

9.  Mechanisms involved in the anti-inflammatory action of a polysulfated fraction from Gracilaria cornea in rats.

Authors:  Chistiane Oliveira Coura; Ricardo Basto Souza; José Ariévilo Gurgel Rodrigues; Edfranck de Sousa Oliveira Vanderlei; Ianna Wivianne Fernandes de Araújo; Natássia Albuquerque Ribeiro; Annyta Fernandes Frota; Kátia Alves Ribeiro; Hellíada Vasconcelos Chaves; Karuza Maria Alves Pereira; Rodrigo Maranguape Silva da Cunha; Mirna Marques Bezerra; Norma Maria Barros Benevides
Journal:  PLoS One       Date:  2015-03-25       Impact factor: 3.240

10.  Interleukin-1β and tumor necrosis factor-α: reliable targets for protective therapies in Parkinson's Disease?

Authors:  María C Leal; Juan C Casabona; Mariana Puntel; Fernando J Pitossi
Journal:  Front Cell Neurosci       Date:  2013-04-29       Impact factor: 5.505

View more
  5 in total

1.  Antidepressant activity of phytochemicals of Mangifera indica seeds assisted by integrated computational analysis.

Authors:  Uzma Saleem; Shafa Iman; Bashir Ahmad; Muhammad Ajmal Shah; Shabana Bibi; Mohammed Alqarni; Muhammad Saad Khan; Ghulam Mujtaba Shah; Haroon Khan; Reem Hasaballah Alhasani; Norah A Althobaiti; Aishah E Albalawi
Journal:  Metab Brain Dis       Date:  2022-03-28       Impact factor: 3.584

2.  α-Glucosidase inhibitory activity of cannabidiol, tetrahydrocannabinol and standardized cannabinoid extracts from Cannabis sativa.

Authors:  Wiwit Suttithumsatid; Muhammad Ajmal Shah; Shabana Bibi; Pharkphoom Panichayupakaranant
Journal:  Curr Res Food Sci       Date:  2022-07-07

3.  Thymoquinone Induces Nrf2 Mediated Adaptive Homeostasis: Implication for Mercuric Chloride-Induced Nephrotoxicity.

Authors:  Shakila Sabir; Uzma Saleem; Muhammad Sajid Hamid Akash; Muhammad Qasim; Zunera Chauhdary
Journal:  ACS Omega       Date:  2022-02-18

4.  In Silico and In Vitro Screening Constituents of Eclipta alba Leaf Extract to Reveal Antimicrobial Potential.

Authors:  Rahul Kumar Sharma; Shabana Bibi; Hitesh Chopra; Muhammad Saad Khan; Navidha Aggarwal; Inderbir Singh; Syed Umair Ahmad; Mohammad Mehedi Hasan; Mahmoud Moustafa; Mohammed Al-Shehri; Abdulaziz Alshehri; Atul Kabra
Journal:  Evid Based Complement Alternat Med       Date:  2022-08-17       Impact factor: 2.650

5.  Dose Dependent Effects of Breynia cernua Against the Paraquat Induced Parkinsonism like Symptoms in Animals' Model: In Vitro, In Vivo and Mechanistic Studies.

Authors:  Malik Saadullah; Sania Arif; Liaqat Hussain; Muhammad Asif; Umair Khurshid
Journal:  Dose Response       Date:  2022-09-09       Impact factor: 2.623

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.